Brief: Proxy Advisory Firms ISS And Glass Lewis Recommend Catalyst Stockholders Vote For All Of The Co's Nominees On The White Proxy Card
03/08/2022 13:49
Aug 3 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* LEADING INDEPENDENT PROXY ADVISORY FIRMS ISS AND GLASS
LEWIS
RECOMMEND CATALYST STOCKHOLDERS VOTE “FOR” ALL OF THE COMPANY’S
NOMINEES ON THE WHITE PROXY CARD
Source text for Eikon: ID:nGNX6d1Hg0
Further company coverage: CBIO.O
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes